Incannex Healthcare Stock Price, News & Analysis
Company Description
Incannex Healthcare (NASDAQ: ixhl) is a publicly traded drug manufacturers - specialty & generic company in the Pharmaceutical Preparations sector. The company has a market capitalization of $41.9M, ranking #5,729 among all listed U.S. companies by market cap.
ixhl stock has declined 85.5% over the past year. Shares last traded at $2.96.
On a trailing twelve-month basis, Incannex Healthcare reported revenue of $86K with net income of -$46.9M and diluted earnings per share of $-1.35. The company operates at a net profit margin of -54517.4%.
This page provides a comprehensive overview of ixhl stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Incannex Healthcare (ixhl) stock last traded at $2.96, down 3.38% from the previous close. Over the past 12 months, the stock has lost 85.5%. At a market capitalization of $41.9M, ixhl is classified as a micro-cap stock with approximately 14.0M shares outstanding.
Latest News
Incannex Healthcare has 10 recent news articles, with the latest published 6 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include buybacks, partnership, offering, clinical trial, stock split. View all ixhl news →
SEC Filings
Incannex Healthcare has filed 5 recent SEC filings, including 4 Form 8-K, 1 Form 424B5. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ixhl SEC filings →
Financial Highlights
Incannex Healthcare generated $86K in revenue over the trailing twelve months, operating income reached -$23.8M (-27661.6% operating margin), and net income was -$46.9M, reflecting a -54517.4% net profit margin. Diluted earnings per share stood at $-1.35. The company generated -$12.5M in operating cash flow. With a current ratio of 2.86, the balance sheet reflects a strong liquidity position.
Upcoming Events
Nasdaq compliance deadline
Incannex Healthcare has 1 upcoming scheduled event. The next event, "Nasdaq compliance deadline", is scheduled for April 20, 2026 (in 18 days). Investors can track these dates to stay informed about potential catalysts that may affect the ixhl stock price.
Short Interest History
Short interest in Incannex Healthcare (ixhl) currently stands at 1.3 million shares, up 50.1% from the previous reporting period, representing 10.1% of the float. Over the past 12 months, short interest has increased by 546.7%. This moderate level of short interest indicates notable bearish positioning.
Days to Cover History
Days to cover for Incannex Healthcare (ixhl) currently stands at 1.3 days, down 63.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 32% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.6 days.
ixhl Company Profile & Sector Positioning
Incannex Healthcare (ixhl) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing ixhl often look at related companies in the same sector, including Scynexis (SCYX), Aytu Biopharma Inc (AYTU), Cumberland Pharmaceuticals Inc (CPIX), Rockwell Med Inc (RMTI), and DURECT (DRRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ixhl's relative position within its industry.